Harvard Bioscience (HBIO) Shares Outstanding (Diluted Average) (2010 - 2026)
Harvard Bioscience (HBIO) reported Shares Outstanding (Diluted Average) of $4.5 million for Q1 2026, down 89.92% on a QoQ basis from $44.4 million in Q4 2025.
Harvard Bioscience (HBIO) has 15 years of Shares Outstanding (Diluted Average) data on file, last reported at $4.5 million in Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) changed N/A year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (changed N/A YoY) and the FY2025 annual result came in at $44.4 million, up 1.96% from the prior year.
- Shares Outstanding (Diluted Average) declined to $4.5 million in Q1 2026 per HBIO's latest filing, from $44.4 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $44.4 million in Q4 2025 and bottomed at $664000.0 in Q1 2023.
- The 5-year median for Shares Outstanding (Diluted Average) is $42.4 million (2023), against an average of $34.7 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) slipped 0.84%; it then surged 6436.45% in 2024.
- Tracing HBIO's Shares Outstanding (Diluted Average) over 5 years: stood at $41.4 million in 2022, then advanced by 2.43% to $42.4 million in 2023, then advanced by 2.64% to $43.5 million in 2024, then increased by 1.96% to $44.4 million in 2025, then plunged by 89.92% to $4.5 million in 2026.
- Per Business Quant, the three latest HBIO Shares Outstanding (Diluted Average) figures stand at $4.5 million (Q1 2026), $44.4 million (Q4 2025), and $43.5 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 145.72 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 72.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 175.50 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 196.70 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 71.61 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 515.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 64.83 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | 4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 44.39 Mn |
| Dec 31, 2024 | 43.54 Mn |
| Mar 31, 2024 | 43.40 Mn |
| Dec 31, 2023 | 42.42 Mn |
| Sep 30, 2023 | 42.35 Mn |
| Jun 30, 2023 | 42.20 Mn |
| Mar 31, 2023 | 664,000.00 |
| Dec 31, 2022 | 41.41 Mn |
| Jun 30, 2022 | 42.56 Mn |
| Sep 30, 2019 | 38.04 Mn |
| Jun 30, 2019 | 37.74 Mn |
| Mar 31, 2019 | 37.64 Mn |
| Dec 31, 2018 | 36.45 Mn |
| Sep 30, 2018 | 36.95 Mn |
| Jun 30, 2018 | 35.77 Mn |
| Mar 31, 2018 | 35.46 Mn |
| Dec 31, 2017 | 34.75 Mn |
| Sep 30, 2017 | 34.84 Mn |
| Jun 30, 2017 | 34.64 Mn |
| Mar 31, 2017 | 34.58 Mn |
| Dec 31, 2016 | 34.21 Mn |
| Sep 30, 2016 | 34.16 Mn |
| Jun 30, 2016 | 34.07 Mn |
| Mar 31, 2016 | 34.01 Mn |
| Dec 31, 2015 | 33.59 Mn |
| Sep 30, 2015 | 33.93 Mn |
| Jun 30, 2015 | 33.24 Mn |
| Mar 31, 2015 | 32.91 Mn |
| Dec 31, 2014 | 33.24 Mn |
| Sep 30, 2014 | 33.10 Mn |
| Jun 30, 2014 | 32.94 Mn |
| Mar 31, 2014 | 32.92 Mn |
| Dec 31, 2013 | 31.91 Mn |
| Sep 30, 2013 | 31.76 Mn |
| Jun 30, 2013 | 31.70 Mn |
| Mar 31, 2013 | 31.67 Mn |
| Dec 31, 2012 | 29.79 Mn |
| Mar 31, 2012 | 29.67 Mn |
| Dec 31, 2011 | 29.82 Mn |
| Sep 30, 2011 | 29.86 Mn |
| Jun 30, 2011 | 30.19 Mn |
| Mar 31, 2011 | 29.50 Mn |
| Dec 31, 2010 | 29.40 Mn |
| Sep 30, 2010 | 28.79 Mn |
| Jun 30, 2010 | 30.04 Mn |